IVASCULAR ANGIOLITE. Sirolimus Release Coronary Stent System - ARCSA Registration 0aea966a1713c3323a0fe1850f0f6e84
Access comprehensive regulatory information for IVASCULAR ANGIOLITE. Sirolimus Release Coronary Stent System in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID 0aea966a1713c3323a0fe1850f0f6e84 and manufactured by LIFE VASCULAR DEVICE BIOTECH S.L. (LVDB). The device was registered on January 25, 2023.
This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
THE DEVICE IS INDICATED TO INCREASE THE INTERNAL DIAMETER OF THE ARTERY IN ORDER TO IMPROVE BLOOD FLOW IN THE FOLLOWING CASES: • PATIENTS WITH SYMPTOMATIC ISCHEMIC HEART DISEASE ASSOCIATED WITH "DE NOVO" OR RESTENOTIC STENOTIC LESIONS IN ARTERIES BETWEEN 2 AND 4.5 MM IN DIAMETER.• PATIENTS WITH OCCLUSIVE DISEASE DUE TO ACUTE MYOCARDIAL INFARCTION IN ARTERIES BETWEEN 2 AND 4.5 MM IN DIAMETER.